The Nrf2 activator methyl bardoxolone exacerbates mitochondrial dysfunction in palmitate-treated breast cancer cells

A. Refaat, C. Pararasa, Jep Brown, A. Ali, H.r. Griffiths

Research output: Contribution to conferenceAbstract

Fingerprint Dive into the research topics of 'The Nrf2 activator methyl bardoxolone exacerbates mitochondrial dysfunction in palmitate-treated breast cancer cells'. Together they form a unique fingerprint.

Medicine & Life Sciences